ENHANCER OF ZESTE HOMOLOG 2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR IMMUNOHISTOCHEMICAL EXPRESSION ARE ASSOCIATED WITH ADVERSE CLINICAL OUTCOME IN NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.